Detalhe da pesquisa
1.
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial.
Lancet
; 403(10432): 1141-1152, 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461841
2.
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
Lancet
; 403(10432): 1153-1163, 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461843
3.
INTRAVITREAL NESVACUMAB (ANTIANGIOPOIETIN 2) PLUS AFLIBERCEPT IN DIABETIC MACULAR EDEMA: Phase 2 RUBY Randomized Trial.
Retina
; 42(6): 1111-1120, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35234673
4.
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial.
JAMA
; 328(4): 348-359, 2022 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35881122
5.
EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT USING A TREAT-AND-EXTEND REGIMEN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The ARIES Study: A Randomized Clinical Trial.
Retina
; 41(9): 1911-1920, 2021 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33782365
6.
Intravitreal Combined Aflibercept + Anti-Platelet-Derived Growth Factor Receptor ß for Neovascular Age-Related Macular Degeneration: Results of the Phase 2 CAPELLA Trial.
Ophthalmology
; 127(2): 211-220, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31791663
7.
The Developing Regorafenib Eye drops for neovascular Age-related Macular degeneration (DREAM) study: an open-label phase II trial.
Br J Clin Pharmacol
; 85(2): 347-355, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30341774
8.
EFFICACY AND SAFETY OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOCUSING ON PATIENTS WITH DIABETIC MACULAR EDEMA FROM JAPAN.
Retina
; 39(5): 938-947, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29470308
9.
Effect of finerenone on the occurrence of vision-threatening complications in patients with non-proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR).
Diabetes Obes Metab
; 25(3): 894-898, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331803
10.
Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.
Ophthalmology
; 123(11): 2376-2385, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27651226
11.
Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.
Ophthalmology
; 122(10): 2044-52, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26198808
12.
Intravitreal aflibercept for diabetic macular edema.
Ophthalmology
; 121(11): 2247-54, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25012934
13.
Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: AZURE, a Randomized Trial of Treat-and-Extend vs. Fixed Dosing.
Adv Ther
; 41(3): 1010-1024, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38183525
14.
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next.
JAMA Netw Open
; 7(4): e248383, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687481
15.
A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy.
Oncologist
; 18(11): 1190-1, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24105751
16.
Intravitreal Nesvacumab (Anti-Angiopoietin-2) Plus Aflibercept in Neovascular AMD: Phase 2 ONYX Randomized Trial.
J Vitreoretin Dis
; 7(1): 8-15, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37008402
17.
Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial.
JAMA Ophthalmol
; 141(9): 834-842, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37535382
18.
One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema.
Ophthalmology
; 119(8): 1658-65, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22537617
19.
Rapid production of SaCas9 in plant-based cell-free lysate for activity testing.
Biotechnol J
; 17(7): e2100564, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35316566
20.
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial.
Adv Ther
; 39(6): 2701-2716, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35412227